InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Friedman Cathy, 董事. Officer active across 3 companies, notably Lyell Immunopharma, Inc.. Aggregated, 6 filings have been published. History available since 14 December 2021. The latest transaction was disclosed on 14 June 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Friedman Cathy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
23,443 股0Class A Common StockSEC:0001209191-23-038186:0
26,800 股@ US$10.00100.0% 占其流量Common StockSEC:0000899243-22-028642:0
9,945 股0Class A Common StockSEC:0001209191-22-038080:0
5,500 股0Common StockSEC:0001209191-22-004785:0
3,765,842 股0Common StockSEC:0001209191-21-069485:0
3,765,842 股Common StockSEC:0001209191-21-042795:0
6 条申报中的 6 条
About Friedman Cathy
Cathy Friedman is a Board Member at Lyell Immunopharma, Inc., Radius Health, Inc., and Seer, Inc. She plays a key role in the governance of these companies, participating in strategic decision-making and guiding operations. Her experience in the biopharmaceutical sector is an asset to the boards, allowing these companies to focus on innovation and growth.
